What contributes more strongly to predicting QOL during 1-year recovery from treatment for clinically localized prostate cancer: 4-weeks-post-treatment depressive symptoms or type of treatment?
详细信息 查看全文
- 作者：Patrick O. Monahan ; Victoria Champion ; Susan Rawl ; R. Brian Giesler ; Barbara Given ; Charles W. Given ; Debra Burns ; Silvia Bigatti ; Kristina M. Reuille and Faouzi Azzouz ; et al.
- 关键词：Depression ; Depressive symptoms ; Prostate cancer ; Quality of life ; Treatment
- 刊名：Quality of Life Research
- 出版年：2007
- 出版时间：April, 2007
- 年：2007
- 卷：16
- 期：3
- 页码：399-411
- 全文大小：201 KB
- 刊物类别：Medicine
- 刊物主题：Medicine & Public Health
Quality of Life Research
Sociology
Public Health - 出版者：Springer Netherlands
- ISSN：1573-2649
文摘
Purpose: Research on prostate cancer and quality of life (QOL) has focused on the effects of treatment type on subsequent QOL, without considering effects of depressive symptoms. The present purpose is to test the independent contribution of depressive symptoms (measured within 4 weeks after treatment) and treatment type in predicting QOL measured 4, 7, and 12 months following treatment for clinically localized prostate cancer.